Abstract
Receptors for the cytokines leukemia inhibitory factor (LIF), interleukin-6 (IL-6), oncostatin M (OSM), ciliary neurotrophic factor (CNTF) and interleukin-11 (IL-11) are members of the structurally conserved hemopoietin receptor superfamily. In addition, they all share the transmembrane signalling protein gp130. In this paper the expression and function of this family of receptors in breast cancer cells was examined. RT – PCR analyses demonstrated that gp130 was expressed in 12/12 breast cell lines and the specific receptor α-chains for IL-6, LIF, IL-11 and CNTF were expressed in the majority of these cell lines. This was in contrast to other hemopoitin receptors. Examination of 50 clinical samples of malignant breast tissue by RT – PCR showed a similar pattern of expression of gp130 associated receptors. Treatment of breast cancer cell lines with OSM resulted in changes in cellular morphology. Cellular proliferation was inhibited following exposure to OSM (3/4 cell lines), IL-11 (2/4 cell lines), and by IL-6 and LIF (1/4 cell lines). Cell surface binding of LIF and OSM was also documented. The expression of these receptors in 12/12 cell lines and greater than 95% of clinical samples suggests that these molecules may be important in regulating the growth of breast cells.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 50 print issues and online access
$259.00 per year
only $5.18 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Douglas, A., Goss, G., Sutherland, R. et al. Expression and function of members of the cytokine receptor superfamily on breast cancer cells. Oncogene 14, 661–669 (1997). https://doi.org/10.1038/sj.onc.1200882
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/sj.onc.1200882
Keywords
- breast cancer
- cytokines
- receptors
- cell growth
- growth factors
This article is cited by
-
Effects of bromodomain and extra-terminal inhibitor JQ1 and interleukin-6 on breast cancer cells
Molecular Biology Reports (2023)
-
HDAC inhibitors induce LIFR expression and promote a dormancy phenotype in breast cancer
Oncogene (2021)
-
Leukemia inhibitory factor: A main controller of breast cancer
Journal of Biosciences (2020)
-
Oncostatin-M promotes phenotypic changes associated with mesenchymal and stem cell-like differentiation in breast cancer
Oncogene (2014)
-
The role of intratumoral and systemic IL-6 in breast cancer
Breast Cancer Research and Treatment (2013)